CRBU / Caribou Biosciences, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Caribou Biosciences, Inc.
US ˙ NasdaqGS ˙ US1420381089

Deler fremragende 96,637,202 shares
Insideraktier3.381.502 shares
Insider ejerskab3,50 %
Total Insiders18
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-4 ( )
10472 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.026% ( )
9776 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Caribou Biosciences, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Albertson Tina M. Chief Medical Officer - [O] 68.523 68.523
Scott Braunstein 27.500
FMR LLC / Fidelity Management & Research - 1.464.775 1.464.775
Ryan Fischesser VP of Finance and Controller - [O] 118.854 118.854
Andrew Guggenhime 27.500
Haurwitz Rachel E. President and CEO, Director - [D] [O] 447.150 447.150
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
David Lee Johnson 44.000
Steven Kanner Chief Scientific Officer - [O] 431.556 431.556
Timothy P Kelly Chief Technology Officer - [O] 73.125 73.125
Ruhi Ahmad Khan Chief Business Officer - [O] 104.998 104.998
Barbara G Mcclung Chief Legal Officer - [O] 481.564 481.564
Jason O'Byrne Chief Financial Officer - [O] 59.224 59.224
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Dara Richardson-Heron 44.000
Syed Ali-aamir Rizvi Chief Medical Officer - [O] 59.373 59.373
Sriram Ryali Chief Financial Officer - [O] 72.360 72.360
Natalie Sacks 27.500
Nancy Whiting 13.060
Ran Zheng 13.750

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CRBU / Caribou Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-03-14 Haurwitz Rachel E. 20.000 1,0200 20.000 1,0200 20.400 215 2.8400 36.400 178,43
2025-01-29 Ryali Sriram 17.360 1,4200 17.360 1,4200 24.651
2022-01-11 Fischesser Ryan 569 2,6900 569 2,6900 1.531
2022-01-11 Fischesser Ryan 6.818 4,1100 6.818 4,1100 28.022
2021-12-20 Fischesser Ryan 1.136 2,6900 1.136 2,6900 3.056
2021-12-07 MCCLUNG BARBARA G 12 2,6900 12 2,6900 32
2021-12-07 MCCLUNG BARBARA G 6.115 2,6900 6.115 2,6900 16.449
2021-10-20 MCCLUNG BARBARA G 9.176 2,6900 9.176 2,6900 24.683
2021-10-20 MCCLUNG BARBARA G 43 2,6900 43 2,6900 116

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CRBU / Caribou Biosciences, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CRBU / Caribou Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-02-25 Kelly Timothy P 6.228 1,9300 6.228 1,9300 12.020 8 1.7100 -1.370 -11,40
2026-02-24 Kelly Timothy P 3.147 1,9600 3.147 1,9600 6.168
2023-01-19 Rizvi Syed Ali-aamir 5.627 6,3100 5.627 6,3100 35.506
2022-10-06 Fischesser Ryan 10.000 10,7958 10.000 10,7958 107.958

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CRBU / Caribou Biosciences, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-02-27 2026-02-25 4 Kelly Timothy P CRBU Common Stock S - Sale D 1,9300 -6.228 -12 73.125
2026-02-24 2026-02-24 4 Kelly Timothy P CRBU Common Stock S - Sale D 1,9600 -3.147 -6 79.353
2026-02-24 2026-02-20 4 Kelly Timothy P CRBU Common Stock A - Award D 45.000 82.500
2026-02-24 2026-02-24 4 Albertson Tina M. CRBU Common Stock S - Sale D 1,9600 -1.066 -2 68.523
2026-02-24 2026-02-20 4 Albertson Tina M. CRBU Common Stock A - Award D 55.000 69.589
2026-02-24 2026-02-24 4 Khan Ruhi Ahmad CRBU Common Stock S - Sale D 1,9600 -6.938 -14 104.998
2026-02-24 2026-02-20 4 Khan Ruhi Ahmad CRBU Common Stock A - Award D 45.000 111.936
2026-02-24 2026-02-24 4 MCCLUNG BARBARA G CRBU Common Stock S - Sale D 1,9600 -6.938 -14 481.564
2026-02-24 2026-02-20 4 MCCLUNG BARBARA G CRBU Common Stock A - Award D 45.000 488.502
2026-02-20 2026-02-20 4 Haurwitz Rachel E. CRBU Common Stock A - Award D 151.700 447.150
2026-02-20 2026-02-20 4 Ryali Sriram CRBU Common Stock A - Award D 55.000 72.360
2025-03-17 2025-03-14 4 Haurwitz Rachel E. By Trust CRBU Common Stock P - Purchase I 1,0200 20.000 20 3.369.395
2025-02-21 2025-02-20 4 Haurwitz Rachel E. CRBU Common Stock A - Award D 136.750 295.450
2025-02-21 2025-02-20 4 Albertson Tina M. CRBU Common Stock A - Award D 14.589 14.589
2025-02-21 2025-02-21 4 Khan Ruhi Ahmad CRBU Common Stock S - Sale D 1,3500 -3.564 -5 66.936
2025-02-21 2025-02-20 4 Khan Ruhi Ahmad CRBU Common Stock A - Award D 37.500 70.500
2025-02-21 2025-02-21 4 MCCLUNG BARBARA G CRBU Common Stock S - Sale D 1,3500 -3.564 -5 443.502
2025-02-21 2025-02-20 4 MCCLUNG BARBARA G CRBU Common Stock A - Award D 37.500 447.066
2025-02-21 2025-02-20 4 Kelly Timothy P CRBU Common Stock A - Award D 37.500 37.500
2025-02-21 2025-02-21 4 Kanner Steven CRBU Common Stock S - Sale D 1,3500 -3.564 -5 431.556
2025-02-21 2025-02-20 4 Kanner Steven CRBU Common Stock A - Award D 37.500 435.120
2025-01-30 2025-01-29 4 Ryali Sriram CRBU Common Stock P - Purchase D 1,4200 17.360 25 17.360
2024-11-22 2024-11-20 4 Fischesser Ryan CRBU Common Stock A - Award D 25.000 118.854
2024-10-04 3 Fischesser Ryan CRBU Common Stock D 93.854
2024-02-22 2024-02-20 4 O'Byrne Jason CRBU Common Stock A - Award D 33.000 59.224
2024-02-22 2024-02-20 4 MCCLUNG BARBARA G CRBU Common Stock A - Award D 33.000 409.566
2024-02-22 2024-02-20 4 Khan Ruhi Ahmad CRBU Common Stock A - Award D 33.000 33.000
2024-02-22 2024-02-20 4 Haurwitz Rachel E. CRBU Common Stock A - Award D 118.700 158.700
2024-02-22 2024-02-20 4 Kanner Steven CRBU Common Stock A - Award D 33.000 387.037
2024-02-08 2024-02-06 4 Kanner Steven CRBU Common Stock M - Exercise D 2,6900 30.577 82 354.037
2023-06-09 2023-06-08 4 Haurwitz Rachel E. CRBU Common Stock M - Exercise D 2,9600 10.000 30 40.000
2023-03-22 2023-03-20 4 Haurwitz Rachel E. CRBU Common Stock M - Exercise D 2,9600 10.000 30 30.000
2023-01-20 2023-01-19 4 Rizvi Syed Ali-aamir CRBU Common Stock S - Sale D 6,3100 -5.627 -36 59.373
2022-12-02 2022-12-02 4 Kanner Steven CRBU Common Stock M - Exercise D 2,6900 21.401 58 323.460
2022-10-07 2022-10-06 4 Fischesser Ryan CRBU Common Stock M - Exercise D 4,1100 2.839 12 116.044
2022-10-07 2022-10-06 4 Fischesser Ryan CRBU Common Stock M - Exercise D 2,6900 2.839 8 113.205
2022-10-07 2022-10-06 4 Fischesser Ryan CRBU Common Stock S - Sale D 10,7958 -10.000 -108 110.366
2022-09-16 2022-09-15 4 MCCLUNG BARBARA G CRBU Common Stock M - Exercise D 2,6900 27.518 74 376.566
2022-09-16 2022-09-15 4 MCCLUNG BARBARA G CRBU Common Stock M - Exercise D 2,6900 77 0 349.048
2022-08-26 2022-08-25 4 Kanner Steven CRBU Common Stock S - Sale D 11,2195 -43.248 -485 302.059
2022-08-26 2022-08-25 4 Kanner Steven CRBU Common Stock M - Exercise D 2,6900 43.248 116 345.307
2022-08-24 2022-08-22 4 Fischesser Ryan CRBU Common Stock A - Award D 4.848 120.366
2022-05-18 2022-05-18 4 JOHNSON DAVID LEE CRBU Option to purchase Common Stock A - Award D 9,12 44.000 44.000
2022-05-17 2022-05-13 4 Kanner Steven CRBU Option to purchase Common Stock M - Exercise D 2,69 -6.114 116.849
2022-05-17 2022-05-13 4 Kanner Steven CRBU Option to purchase Common Stock M - Exercise D 1,81 -68.306 3.534
2022-05-17 2022-05-13 4 Kanner Steven CRBU Common Stock M - Exercise D 2,6900 6.114 16 302.059
2022-05-17 2022-05-13 4 Kanner Steven CRBU Common Stock M - Exercise D 1,8100 68.306 124 295.945
2022-05-10 2022-01-26 4/A Haurwitz Rachel E. CRBU Option to purchase Common Stock M - Exercise D 2,96 -10.000 126.350
2022-05-10 2022-01-26 4/A Haurwitz Rachel E. CRBU Common Stock M - Exercise D 2,9600 10.000 30 10.000
2022-05-10 2022-05-09 4 Haurwitz Rachel E. CRBU Option to purchase Common Stock M - Exercise D 2,96 -10.000 116.350
2022-05-10 2022-05-09 4 Haurwitz Rachel E. CRBU Common Stock M - Exercise D 2,9600 10.000 30 20.000
2022-05-06 2022-05-05 4 Fischesser Ryan CRBU Option to purchase Common Stock M - Exercise D 4,11 -1.138 18.176
2022-05-06 2022-05-05 4 Fischesser Ryan CRBU Option to purchase Common Stock M - Exercise D 2,69 -1.136 4.543
2022-05-06 2022-05-05 4 Fischesser Ryan CRBU Common Stock M - Exercise D 4,1100 1.138 5 115.518
2022-05-06 2022-05-05 4 Fischesser Ryan CRBU Common Stock M - Exercise D 2,6900 1.136 3 114.380
2022-03-17 2022-03-15 4 Fischesser Ryan CRBU Option to purchase Common Stock M - Exercise D 4,11 -1.138 19.314
2022-03-17 2022-03-15 4 Fischesser Ryan CRBU Option to purchase Common Stock M - Exercise D 2,69 -1.136 5.679
2022-03-17 2022-03-15 4 Fischesser Ryan CRBU Common Stock M - Exercise D 4,1100 1.138 5 113.244
2022-03-17 2022-03-15 4 Fischesser Ryan CRBU Common Stock M - Exercise D 2,6900 1.136 3 112.106
2022-03-07 2022-03-04 4 Kanner Steven CRBU Option to purchase Common Stock M - Exercise D 4,11 -1.549 230.365
2022-03-07 2022-03-04 4 Kanner Steven CRBU Option to purchase Common Stock M - Exercise D 2,69 -9.171 122.963
2022-03-07 2022-03-04 4 Kanner Steven CRBU Common Stock M - Exercise D 4,1100 1.549 6 227.639
2022-03-07 2022-03-04 4 Kanner Steven CRBU Common Stock M - Exercise D 2,6900 9.171 25 226.090
2022-02-09 2021-09-27 5 Haurwitz Rachel E. By Trust CRBU Common Stock G - Gift I 3.349.395 3.349.395
2022-02-09 2021-09-27 5 Haurwitz Rachel E. CRBU Common Stock G - Gift D -3.349.395 0
2022-02-08 2022-02-08 4 O'Byrne Jason CRBU Option to purchase Common Stock M - Exercise D 4,11 -24.336 412.865
2022-02-08 2022-02-08 4 O'Byrne Jason CRBU Common Stock M - Exercise D 4,1100 24.336 100 24.336
2022-01-27 2022-01-26 4 Haurwitz Rachel E. CRBU Option to purchase Common Stock M - Exercise D 2,96 -10.000 126.350
2022-01-27 2022-01-26 4 Haurwitz Rachel E. CRBU Common Stock M - Exercise D 2,9600 10.000 30 3.359.395
2022-01-25 2022-01-25 4 Rizvi Syed Ali-aamir CRBU Option to purchase common stock A - Award D 10,64 161.250 161.250
2022-01-25 2022-01-25 4 Rizvi Syed Ali-aamir CRBU Common stock A - Award D 60.000 65.000
2022-01-24 3 Rizvi Syed Ali-aamir CRBU Common Stock D 5.000
2022-01-12 2022-01-11 4 Fischesser Ryan CRBU Option to purchase Common Stock X - Other D 4,11 -6.818 20.452
2022-01-12 2022-01-11 4 Fischesser Ryan CRBU Option to purchase Common Stock X - Other D 2,69 -569 6.815
2022-01-12 2022-01-11 4 Fischesser Ryan CRBU Common Stock P - Purchase D 4,1100 6.818 28 109.082
2022-01-12 2022-01-11 4 Fischesser Ryan CRBU Common Stock P - Purchase D 2,6900 569 2 102.264
2021-12-22 2021-12-20 4/A Whiting Nancy CRBU Option to purchase Common Stock A - Award D 15,16 13.060 13.060
2021-12-21 2021-12-20 4 Zheng Ran CRBU Option to purchase Common Stock A - Award D 15,16 13.750 13.750
2021-12-21 2021-12-20 4 Whiting Nancy CRBU Option to purchase Common Stock A - Award D 15,16 13.750 13.750
2021-12-21 2021-12-20 4 Sacks Natalie CRBU Option to purchase Common Stock A - Award D 15,16 27.500 27.500
2021-12-21 2021-12-20 4 O'Byrne Jason CRBU Option to purchase Common Stock A - Award D 15,16 147.000 147.000
2021-12-21 2021-12-20 4 MCCLUNG BARBARA G CRBU Option to purchase Common Stock A - Award D 15,16 147.000 147.000
2021-12-21 2021-12-20 4 Kanner Steven CRBU Option to purchase Common Stock A - Award D 15,16 147.000 147.000
2021-12-21 2021-12-20 4 Haurwitz Rachel E. CRBU Option to purchase Common Stock A - Award D 15,16 411.000 411.000
2021-12-21 2021-12-20 4 GUGGENHIME ANDREW CRBU Option to purchase Common Stock A - Award D 15,16 27.500 27.500
2021-12-21 2021-12-20 4 Fischesser Ryan CRBU Option to purchase Common Stock A - Award D 15,16 40.000 40.000
2021-12-21 2021-12-20 4 Fischesser Ryan CRBU Option to purchase Common Stock X - Other D 2,69 -1.136 7.384
2021-12-21 2021-12-20 4 Fischesser Ryan CRBU Common Stock P - Purchase D 2,6900 1.136 3 101.695
2021-12-21 2021-12-20 4 Braunstein Scott CRBU Option to purchase Common Stock A - Award D 15,16 27.500 27.500
2021-12-08 2021-12-07 4 MCCLUNG BARBARA G CRBU Option to purchase Common Stock X - Other D 2,69 -6.115 74.836
2021-12-08 2021-12-07 4 MCCLUNG BARBARA G CRBU Option to purchase Common Stock X - Other D 2,69 -12 77
2021-12-08 2021-12-07 4 MCCLUNG BARBARA G CRBU Common Stock P - Purchase D 2,6900 6.115 16 348.971
2021-12-08 2021-12-07 4 MCCLUNG BARBARA G CRBU Common Stock P - Purchase D 2,6900 12 0 342.856
2021-11-16 2021-11-15 4 Khan Ruhi Ahmad CRBU Option to purchase Common Stock A - Award D 21,73 225.000 225.000
2021-11-15 2021-11-11 4 Richardson-Heron Dara CRBU Option to purchase Common Stock A - Award D 20,52 44.000 44.000
2021-10-21 2021-10-20 4 MCCLUNG BARBARA G CRBU Option to purchase Common Stock X - Other D 2,69 -43 89
2021-10-21 2021-10-20 4 MCCLUNG BARBARA G CRBU Option to purchase Common Stock X - Other D 2,69 -9.176 80.951
2021-10-21 2021-10-20 4 MCCLUNG BARBARA G CRBU Common Stock P - Purchase D 2,6900 43 0 342.844
2021-10-21 2021-10-20 4 MCCLUNG BARBARA G CRBU Common Stock P - Purchase D 2,6900 9.176 25 342.801
2021-10-13 2021-10-12 4 Kanner Steven CRBU Option to purchase Common Stock X - Other D 2,69 -14.614 132.134
2021-10-13 2021-10-12 4 Kanner Steven CRBU Option to purchase Common Stock X - Other D 1,81 -698 4.879
2021-10-13 2021-10-12 4 Kanner Steven CRBU Option to purchase Common Stock X - Other D 1,81 -99.548 71.840
2021-10-13 2021-10-12 4 Kanner Steven CRBU Common Stock P - Purchase D 2,6900 14.614 39 215.031
2021-10-13 2021-10-12 4 Kanner Steven CRBU Common Stock P - Purchase D 1,8100 698 1 200.417
2021-10-13 2021-10-12 4 Kanner Steven CRBU Common Stock P - Purchase D 1,8100 99.548 180 199.719
2021-10-12 2021-10-11 4 Fischesser Ryan CRBU Option to purchase Common Stock X - Other D 2,69 -1.746 8.520
2021-10-12 2021-10-11 4 Fischesser Ryan CRBU Common Stock P - Purchase D 2,6900 1.746 5 100.559
2021-10-04 2021-10-01 4 Zheng Ran CRBU Stock Option (right to buy) A - Award D 22,31 44.000 44.000
2021-09-09 2021-09-08 4 Whiting Nancy CRBU Stock Option (right to buy) A - Award D 28,32 44.000 44.000
2021-07-29 2021-07-27 4 FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership CRBU Series A-1 Preferred Stock C - Conversion I -805.707 0
2021-07-29 2021-07-27 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP CRBU Series A-1 Preferred Stock C - Conversion I -9.666 0
2021-07-29 2021-07-27 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP CRBU Series A-1 Preferred Stock C - Conversion I -588.794 0
2021-07-29 2021-07-27 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP CRBU Series B Preferred Stock C - Conversion I -423.823 0
2021-07-29 2021-07-27 4 FMR LLC / Fidelity Management & Research Impresa Fund III Limited Partnership CRBU Common Stock C - Conversion I 1.464.775 1.464.775
2021-07-29 2021-07-27 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Advisors Fund IV LP CRBU Common Stock C - Conversion I 17.572 17.572
2021-07-29 2021-07-27 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP CRBU Common Stock C - Conversion I 1.070.427 1.840.937
2021-07-29 2021-07-27 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Healthcare Fund IV LP CRBU Common Stock C - Conversion I 770.510 770.510
2021-07-23 3 Fischesser Ryan CRBU Common Stock D 98.813
2021-07-22 3 MCCLUNG BARBARA G CRBU Common Stock D 333.626
2021-07-22 3 Kanner Steven CRBU Common Stock D 100.171
2021-07-22 3 Haurwitz Rachel E. CRBU Common Stock D 3.349.395
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista